During the past decade, Universitätsklinik für Innere Medizin III conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinik für Innere Medizin III" #1 sponsor was "Hansa Biopharma AB" with 2 trials, followed by "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Alexandra Kautzky-Willer" with 1 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored and "ChemoCentryx" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinik für Innere Medizin III" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinik für Innere Medizin III" are "Fabry Disease" (3 trials), "Kidney Transplant Rejection" (2 trials), "Chronic Kidney Disease" (1 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Universitätsklinik für Innere Medizin III" in a lesser frequency.

Most popular intervention types in "Universitätsklinik für Innere Medizin III" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Imlifidase" (2 trials), "Lucerastat" (2 trials), "CCX282-B" (1 trials) and "Dapagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinik für Innere Medizin III" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinik für Innere Medizin III". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universitätsklinik für Innere Medizin III, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinik für Innere Medizin III, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".